Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Rome Foundation Working T… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome

Artikel i vetenskaplig tidskrift
Författare G. Barbara
M. Grover
P. Bercik
M. Corsetti
U. C. Ghoshal
Lena Öhman
M. Rajilic-Stojanovic
Publicerad i Gastroenterology
Volym 156
Nummer/häfte 1
Sidor 46-+
ISSN 0016-5085
Publiceringsår 2019
Publicerad vid Institutionen för biomedicin, avdelningen för mikrobiologi och immunologi
Sidor 46-+
Språk en
Länkar dx.doi.org/10.1053/j.gastro.2018.07...
Ämnesord Gastrointestinal Infection, Microbiome, Campylobacter, Serotonin, Barrier Function, bile-acid malabsorption, functional gastrointestinal disorders, enterochromaffin cell hyperplasia, placebo-controlled trial, low fodmap, diet, follow-up, bacterial gastroenteritis, mouse model, interstitial-cells, double-blind, Gastroenterology & Hepatology, ewart gt, 1950, bmj-british medical journal, v1, p405, audhary na, 1962, quarterly journal of medicine, v31, p307
Ämneskategorier Gastroenterologi

Sammanfattning

BACKGROUND & AIMS: The existence of postinfection irritable bowel syndrome (PI-IBS) has been substantiated by epidemiology studies conducted in diverse geographic and clinical settings. However, the available evidence has not been well summarized, and there is little guidance for diagnosis and treatment of PI-IBS. The ROME Foundation has produced a working team report to summarize the available evidence on the pathophysiology of PI-IBS and provide guidance for diagnosis and treatment, based on findings reported in the literature and clinical experience. METHODS: The working team conducted an evidence-based review of publication databases for articles describing the clinical features (diagnosis), pathophysiology (intestinal sensorimotor function, microbiota, immune dysregulation, barrier dysfunction, enteroendocrine pathways, and genetics), and animal models of PI-IBS. We used a Delphi-based consensus system to create guidelines for management of PI-IBS and a developed treatment algorithm based on published findings and experiences of team members. RESULTS: PI-IBS develops in about 10% of patients with infectious enteritis. Risk factors include female sex, younger age, psychological distress during or before acute gastroenteritis, and severity of the acute episode. The pathogenesis of PI-PBS appears to involve changes in the intestinal microbiome as well as epithelial, serotonergic, and immune system factors. However, these mechanisms are incompletely understood. There are no evidence-based, effective pharmacologic strategies for treatment of PI-IBS. We provide a consensus-based treatment algorithm, based on clinical presentation and potential disease mechanisms. CONCLUSIONS: Based on a systematic review of the literature and team experience, we summarize the clinical features, pathophysiology (from animal models and human studies), and progression of PI-IBS. Based on these findings, we present an algorithm for diagnosis and treatment of PI-IBS based on team consensus. We also propose areas for future investigation.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?